Clinical trials
Recruiting Phase 3 Pulmonary Embolism trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Regeneron Pharmaceuticals | 4 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Jesper Kjaergaard | 1 |
| NYU Langone Health | 1 |
| Prof. Stavros Konstantinides, MD | 1 |
| Quercis Pharma AG | 1 |
| Supergene, LLC | 1 |
| University Hospital, Angers | 1 |
| University of Calgary | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Embolism | 12 |
| Venous Thrombosis | 8 |
| Venous Thromboembolism | 7 |
| Neoplasms | 2 |
| Atrial Fibrillation | 1 |
| Emergencies | 1 |
| Hemorrhage | 1 |
| Ischemic Stroke | 1 |
| Pancreatic Neoplasms | 1 |
| Postpartum Hemorrhage | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.